During the past decade, Beverly Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 29 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 23 clinical trials were completed. i.e. 127.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beverly Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beverly Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Beverly Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIIB Lung Cancer AJCC v8" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (5 trials). Many other conditions were trialed in "Beverly Hospital" in a lesser frequency.

Most popular intervention types in "Beverly Hospital" are "Drug" (56 trials), "Other" (46 trials), "Biological" (31 trials), "Procedure" (13 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (16 trials), "Docetaxel" (12 trials), "Carboplatin" (9 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Beverly Hospital" are 56 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Beverly Hospital". undefined are not yet recruiting, 16 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Beverly Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Beverly Hospital, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".